Inhibrx Biosciences, Inc. financial data

Symbol
INBX on Nasdaq
Location
11025 N. Torrey Pines Road, Suite 140, La Jolla, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.5M shares
Common Stock, Shares, Outstanding 14.5M shares
Common Stock, Value, Issued 1K USD
Weighted Average Number of Shares Outstanding, Basic 15.5M shares +31.2%
Weighted Average Number of Shares Outstanding, Diluted 15.5M shares +31.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Research and Development Expense 38.9M USD +2.2%
General and Administrative Expense 7.9M USD +0.19%
Operating Income (Loss) -46.8M USD -2.12%
Nonoperating Income (Expense) 2.93M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -43.9M USD +15.3%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -43.9M USD +15.3%
Earnings Per Share, Basic -2.84 USD/shares +35.3%
Earnings Per Share, Diluted -2.84 USD/shares +35.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 196M USD
Other Assets, Current 748K USD
Assets, Current 207M USD
Property, Plant and Equipment, Net 6.88M USD
Operating Lease, Right-of-Use Asset 1.53M USD
Other Assets, Noncurrent 6.71M USD
Assets 223M USD
Accounts Payable, Current 12.4M USD
Employee-related Liabilities, Current 6.47M USD
Accrued Liabilities, Current 29.9M USD
Liabilities, Current 44.1M USD
Operating Lease, Liability, Noncurrent 0 USD
Liabilities 44.1M USD
Retained Earnings (Accumulated Deficit) -58.3M USD
Stockholders' Equity Attributable to Parent 178M USD +37.7%
Liabilities and Equity 223M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 120M shares
Common Stock, Shares, Issued 14.5M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 196M USD -41.8%
Operating Lease, Liability 1.84M USD
Lessee, Operating Lease, Liability, to be Paid 1.89M USD
Property, Plant and Equipment, Gross 15.1M USD
Operating Lease, Liability, Current 1.84M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.14M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 57K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares
Additional Paid in Capital 237M USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 760K USD +150%
Share-based Payment Arrangement, Expense 1.8M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares